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INTROduCTION Endothelial dysfunction, char‑
acterized by the loss of nitric oxide bioavailabili‑
ty, is the key element in the pathogenesis of ath‑
erosclerosis. The significance of endothelial dys‑
function has been demonstrated by numerous 
animal model studies1 and has been confirmed 
in clinical studies showing that it precedes clin‑
ical and morphological atherosclerotic chang‑
es.2 Numerous studies have described associations 
between endothelial dysfunction and risk factors 
for cardiovascular diseases.3‑5 Impaired endothe‑
lial function is a feature of aging and is present in 
patients with high levels of low‑density lipopro‑
teins, arterial hypertension, diabetes, acute cor‑
onary syndromes, autoimmune diseases, and in 
smokers.3‑6 Moreover, the number of atheroscle‑
rotic risk factors has been linked to the degree of 
endothelial dysfunction.7,8
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AbsTRACT
INTROduCTION Endothelial dysfunction, characterized by the loss of nitric oxide bioavailability, is a key 
element in the pathogenesis of atherosclerosis and an important prognostic factor in cardiovascular 
diseases. Therefore, the development of reliable, safe, and noninvasive methods of endothelial function 
assessment is important for their use in cardiovascular risk stratification. Brachial artery flow‑mediated 
dilation (FMD) is widely used in research but technical difficulties and problems with calibration between 
laboratories limit its clinical use. Reactive hyperemia–peripheral artery tonometry (RH‑PAT, EndoPAT) has 
been developed as a simpler, cheaper, and potentially more reproducible method.
ObjECTIvEs We aimed to investigate associations between RH‑PAT and FMD in relation to atheroscle‑
rotic risk factor profile.
PATIENTs ANd mEThOds The study involved 80 subjects (52 men, 28 women) aged 43.6 ±14.8 years, 
with moderate‑to‑low cardiovascular risk (mean SCORE, 2.2% ±2%), in whom FMD, RH‑PAT, and 
intima–media thickness (IMT) were determined.
REsuLTs The reactive hyperemia index (RHI) measured by RH‑PAT correlated with FMD (r = 0.35, 
P <0.01). However, no significant correlation was observed between RHI and IMT, SCORE, or the number 
of classical atherosclerotic risk factors (hypertension, smoking, diabetes, hypercholesterolemia), while 
FMD was significantly correlated with IMT (r = –0.53, P <0.001), risk factors (r = –0.55, P <0.05), 
and SCORE (r = –0.4, P <0.05).
CONCLusIONs Despite its technical requirements, FMD is a more sensitive method than RH‑PAT in 
evaluating the effect of classical atherosclerotic risk factors on vascular endothelial function. Microvas‑
culature response during RH‑PAT needs to be further studied, including the assessment of nonendothelial 
factors that may affect the measurements, before RH‑PAT becomes the universal tool for the evaluation 
of the endothelial cells.
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≥140/90 mmHg or current treatment with an‑
tihypertensive agents), and smoking (current or 
within last 6 months).9 The exclusion criteria in‑
cluded active cancer, acute and chronic infections 
(past 3 months), necessity for continued use of 
vasoactive drugs known to interfere with endo‑
thelial function measurements, life expectancy of 
<3 years, pulmonary hypertension, use of steroids 
or immunosuppressive agents, renal insufficien‑
cy, history of acute coronary syndromes, pregnan‑
cy or breastfeeding, and history of alcohol abuse. 
Ultrasound assessment of atherosclerosis based 
on the measurement of the carotid artery inti‑
ma–media thickness (IMT) was performed. En‑
dothelial function was assessed using brachial ar‑
tery FMD and RH‑PAT measurement. Nitroglyc‑
erine‑mediated dilation (NMD) assessment was 
used as control for FMD. FMD and NMD were 
studied at least 30 min after RH‑PAT to allow for 
the recovery between hyperemia stimuli. In pre‑
liminary experiments, investigations were also 
performed on separate days but this was identi‑
fied as not necessary. Both measurements were 
performed in a dimmed, temperature‑controlled 
room. Participants were recommended to fast 
and refrain from smoking for at least 8 h and to 
refrain from coffee and caffeine/vitamin C‑con‑
taining drinks, alcohol, fatty foods, or exercise 
for at least 10 h prior to the study. Moreover, be‑
fore the study, vasodilating drugs known to af‑
fect endothelial function measurements were dis‑
continued for at least 12 h. Peripheral blood from 
the antecubital vein was taken and fasting blood 
glucose and lipid profile were measured. The study 
was approved by the Local Ethics Committee and 
written informed consent was obtained from all 
participants.
brachial artery ultrasound flow‑mediated dilation 
Endothelial function was assessed by FMD, 
which is based on the measurement of the bra‑
chial artery diameter before and after acute 
5‑minute‑long brachial artery occlusion (using 
the sphygmomanometer cuff) as described be‑
fore, using techniques consistent with the guide‑
lines.10  Measurements were performed with 
the Toshiba Xario Diagnostic Ultrasound Sys‑
tem (Toshiba, United States) and a 8MHz linear 
transducer. All tests were performed by 2 experi‑
enced operators (GW and GO). Before the exami‑
nation, patients were maintained in a supine posi‑
tion for 15 minutes in a calm and darkened room. 
Assessments were performed on the right brachial 
artery, after arm immobilization. Blood pressure 
cuff was placed around the right arm. The mea‑
surement site was identified and marked 3 to 
8 cm proximally from the right antecubital fos‑
sa and a vascular transducer was fixed at the site. 
Depth and gain settings were optimized to iden‑
tify the lumen and vessel wall interface. The mea‑
surements were recorded before cuff inflation to 
at least 200 mmHg (50 mmHg above the systol‑
ic blood pressure level, to achieve brachial artery 
occlusion, for 5 min) and then subsequently 1, 2, 
Considering the above data, endothelial dys‑
function is an important prognostic factor in car‑
diovascular diseases. However, the determination 
of endothelial function has not yet been routine‑
ly included in risk assessment recommended by 
major cardiovascular guidelines. This has been 
mostly associated with the difficulties in devel‑
oping fully reproducible noninvasive methods for 
the endothelial function assessment. Such tech‑
niques are based on the fact that nitric oxide leads 
to vasodilation, which can be quantified becom‑
ing a measure of assessing endothelial function 
or its disturbances.
Quantitative intravascular ultrasound coro‑
nary angiography following intracoronary ace‑
tylcholine infusion is an example of an invasive 
method. It is accurate and sensitive but, at the 
same time, invasive, expensive, and bears sub‑
stantial risk of complications, limiting its wid‑
er clinical application (imperative for the use in 
risk stratification). Flow‑mediated dilation (FMD) 
measurement is an example of noninvasive ap‑
proach, which uses ultrasound measurement of 
an increase in the brachial artery diastolic diam‑
eter in response to blood flow. The measurement 
requires high‑frequency linear transducers, good 
ultrasound system, and an experienced operator. 
Therefore, new noninvasive techniques have been 
developed in an attempt to make endothelial dys‑
function assessment more accessible in general 
medical practice. The reactive hyperemia–periph‑
eral artery tonometry (RH‑PAT) is a much simpler 
and cheaper method and can potentially provide 
better interobserver reproducibility. A number 
of questions regarding the mechanism of the re‑
sponse or the role of ischemic metabolites in va‑
sodilation have been raised, challenging the val‑
ue of RH‑PAT. Accordingly, the aim of the pres‑
ent study was to investigate the associations be‑
tween RH‑PAT and FMD as well as between these 
measures of endothelial function and atheroscle‑
rotic risk factors and severity of atherosclerosis.
PATIENTs ANd mEThOds subjects and protocols 
The study was conducted in 80 subjects (52 men, 
28 women) aged 43.6 ±14.8 years, in whom ath‑
erosclerotic risk was assessed. In each patient, de‑
tailed, questionnaire‑based medical history was 
taken, with emphasis on atherosclerotic risk fac‑
tors (hypertension, hypercholesterolemia, obe‑
sity, diabetes, and smoking), and a physical ex‑
amination was performed, including 3 measure‑
ments of resting blood pressure as well as an‑
thropometric assessment with the calculation of 
the body mass index (BMI). Coronary artery dis‑
ease was defined by clinical history of acute coro‑
nary events or positive result of coronary angiog‑
raphy. None of the patients suffered from myo‑
cardial infarction. Clinical risk factors were de‑
fined as follows: hypercholesterolemia (total plas‑
ma cholesterol level >5 mmol/l); diabetes (fasting 
glucose level ≥7 mmol/l, hemoglobin A1c >6.5%, 
or current treatment with insulin or oral hypo‑
glycemic agents), hypertension (blood pressure 
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according to the manufacturer’s instructions and 
in accordance with the current literature.12‑15
Carotid artery intima–media thickness  The IMT 
measurement was performed using the same de‑
vice and by the same investigator. The measure‑
ments were taken using the standard method. 
Briefly, assessments were performed at 12 dif‑
ferent points (2 cm below the common carotid 
arteries bulbs, about every 1 cm, omitting visi‑
ble coronary plaques), on the right and left com‑
mon carotid arteries, measuring the distance be‑
tween the border between the artery lumen and 
carotid artery intima and second bright M‑line 
(the border between the media and adventitia). 
The obtained images were digitally recorded, 
transferred to the computer, and analyzed us‑
ing the Image Pro Plus software. On the basis of 
the 12 measurements, the mean and maximum 
IMT were calculated (IMTmean and IMTmax, respec‑
tively). Normal IMT was defined as the IMT of 
less than 0.9 mm.16
statistical analysis The results were shown using 
descriptive statistical methods, including ranges, 
means, standard deviations, and percentage dis‑
tributions. Statistical analyses were performed us‑
ing Statistica 10.0 PL, (StatSoft, Poland). The Box–
Cox transformation was applied to achieve nor‑
mal distribution of FMD, NMD, IMT, and RHI 
results. The comparison of normally distribut‑
ed variables in the groups with and without ath‑
erosclerotic risk factors was performed using 
the t test, while when normal range was lacking, 
the Mann–Whitney U test was used. The anal‑
ysis of associations between FMD, NMD, IMT, 
and RHI and atherosclerotic risk factors was per‑
formed using the Spearman’s correlation coeffi‑
cient calculation. For determining interobserv‑
er variability of the FMD measurements, Bland– 
–Altman plots were constructed and the coeffi‑
cient of repeatability was calculated (1.96 times 
the standard deviation of the difference between 
the measurements by independent observers). 
The limits of agreement were defined as the mean 
difference plus and minus 1.96 times the stan‑
dard deviation of the differences. The results were 
statistically significant at a P value of less than 
0.05. The power analysis indicated that to detect 
a simple correlation r (r = 0.4) using a two‑sided 
test, 5% significance level test (α = 0.05) with 
80% power (β = 0.2), the required minimal sam‑
ple size was approximately 47.
REsuLTs Patient characteristics The  study 
group included subjects at  the  age of 19  to 
68 years (52 men and 28 women; mean age, 
43.6 ±14.8 years). The most prevalent athero‑
sclerotic risk factors were hypercholesterolemia 
(n = 53; 66.2%), overweight or obesity (BMI 
≥25.0 kg/m2; n = 51; 63.7%), and hypertension 
(treated and untreated; n = 41; 51.2%). Six pa‑
tients suffered from diabetes. The mean SCORE 
was 2.2% ±2%. Treatments used in these patients 
and 5 min after cuff deflation. The measurements 
during diastole were recorded and maximum di‑
lation was usually detected within approximate‑
ly 60 to 120 s of reactive hyperemia.
NMD was measured to study non‑endothe‑
lium‑dependent vasodilations. Similarly to 
the measurements of FMD, a vessel diameter 
was assessed before the use of nitroglycerine 
(Nitromint, aerosol, 400 µg s.l. EGIS Pharma) 
and 1, 2, and 5 min after sublingual nitroglycer‑
in application.
Studies were recorded on CDs and images were 
transferred to a computer for measurement aided 
by the edge detection software, Image Pro Plus, or 
with Vascular Research Tools 5 (Medical Imaging 
Applications, LLC, United States). Calculations of 
the vessel diameter, measured as a distance be‑
tween the two M‑lines, the one close to the trans‑
ducer and the one distant from the transducer, 
were performed according to the original Celerma‑
jer’s methodology.10 Maximum FMD (FMDmax%) 
and NMD (NMDmax%) were defined as: FMDmax% 
= 100 × (maximum vascular diameter after reac‑
tive hyperemia – basal vascular diameter) / basal 
vascular diameter, while NMDmax% = 100 × (maxi‑
mum vascular diameter after nitrogycerin – basal 
vascular diameter) / basal vascular diameter.11 In 
a subset of patients (n = 10), the data were ac‑
quired by 2 independent observers and the Bland–
Altman analysis was performed using GraphPad 
Prism. The mean difference between the measure‑
ments (bias) was 0.02 for interobserver variabil‑
ity for testing with the limits of agreement be‑
tween 1.8 and 1.77. For interobserver variability 
for analysis these value was 0.03 with the limits 
of agreement between 0.68 and 0.62. Correspond‑
ing correlation coefficients were r = 0.95 and r = 
0.99, and coefficients of repeatability were 1.8 for 
testing and 0.8 for analysis.
Reactive hyperemia–peripheral artery tonometry 
The RH‑PAT measurement was performed us‑
ing Endo‑PAT 2000 (Itamar Medical Ltd, Caesar‑
ea, Israel) in a quiet, dimmed, and temperature‑ 
‑controlled room following the manufacturer’s 
recommendations. The measurements were au‑
tomatically analyzed to obtain the reactive hy‑
peremia index (RHI) using the EndoPATTM soft‑
ware, version 3.1.2 (Itamar Medical, Israel). Be‑
fore the examination, patients remained in a su‑
pine position for 15 min. First, PAT sensors were 
placed on the index fingers of the right and left 
hands. The right arm was tested, while the left 
provided information about the whole body ho‑
meostasis and served as control. Each measure‑
ment consisted of 5 min of basal recording, 5 min 
of right brachial artery occlusion, and 5 min of 
reactive hyperemia measurement. Brachial ar‑
tery occlusion was performed using the sphyg‑
momanometer cuff, which was inflated to at least 
60 mmHg over a patient’s systolic blood pres‑
sure level (minimum, 200 mmHg; maximum, 
about 300 mmHg). All studies were done strictly 
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and ranged between 0.4 and 0.9 mm. As expect‑
ed, there was a significant negative correlation be‑
tween the IMTmean with maximum FMD (FMDmax%; 
r = –0.53; P = 0.000001; FIGuRE 3A), while no associ‑
ation was found with NMD (FIGuRE 3b). Surprising‑
ly, there was no association between the IMTmean 
and RHI in the study group (r = 0.007; P = 0.94; 
FIGuRE 3C).
Quantitative measures of vascular dysfunction and 
atherosclerotic risk factors In further analyses, 
we compared the noninvasive methods of en‑
dothelial function assessment (FMDmax%, RHI), 
IMT in 2 groups of subjects: patients with at least 
1 classical risk factor for atherosclerosis (n = 69) 
and controls without known classical risk factors 
for atherosclerosis (n = 11). As expected, FMDmax% 
was significantly decreased and IMTmean was sig‑
nificantly increased in patients with classical ath‑
erosclerotic risk factors when compared with 
those without analyzed risk factors (FIGuRE 4AC). 
The NMDmax did not differ between the groups 
(FIGuRE 4b). There was no difference in the RHI be‑
tween the groups (FIGuRE 4d). Subsequently, we an‑
alyzed correlations between the number of ath‑
erosclerotic risk factors and measures of endo‑
thelial dysfunction or carotid atherosclerosis. 
The study group consisted of 11 subjects with‑
out any atherosclerotic risk factors, 19 with 1 risk 
factor, 12 with 2, 28 with 3, and 10 with 4 risk fac‑
tors. An increasing number of the risk factors was 
associated with lower FMDmax% (analysis of vari‑
ance [ANOVA]: P = 0.0007; Spearman’s correla‑
tion: Rs = –0.55, P <0.05; FIGuRE 5A), but not NMD 
(FIGuRE 5b), and increased IMT (ANOVA; P <0.05; 
Rs = 0.78, P <0.05; FIGuRE 5C). There was no signif‑
icant association between the RHI and number 
of major atherosclerotic risk factors (ANOVA: P = 
0.54; Rs = –0.06, P  >0.5; FIGuRE 5d). These relation‑
ships were maintained when the analysis was per‑
formed in 66 patients having excluded high‑risk 
patients with coronary artery disease or diabetes. 
In the subgroup with the average SCORE of 1.7 ±2, 
a significant correlation between the number of 
risk factors and FMD was observed (r = –0.5, P 
<0.05), while still no relationship was found with 
the RHI (r = 0.12, P = 0.3). Similarly, no correla‑
tion between the RHI and IMT (r = 0.06, P = 0.3) 
was noted in this subgroup. Finally, in the whole 
group, there was a significant correlation of the 
risk calculated by SCORE with FMD (r = –0.4, P 
<0.05) but not with RHI.
Correlations between individual atherosclerotic risk 
factors and Fmd and Rh‑PAT Certain risk fac‑
tors might be associated with significantly dif‑
ferent results using RH‑PAT compared with FMD. 
Therefore, we next analyzed the effect of individ‑
ual risk factors on FMD and RH‑PAT and found 
that FMD was associated with several risk fac‑
tors, predominantly hypertension in a multivar‑
iate analysis (TAbLE 2), while there was a border‑
line association between RH‑PAT and hypercho‑
lesterolemia (TAbLE 3).
corresponded to a risk factor profile. Clinical 
characteristics of the patients are summarized 
in TAbLE 1. The mean IMT was 0.67 ±0.13 mm.
Endothelial dysfunction Endothelial function 
was assessed independently using FMD/NMD 
and RH‑PAT. The mean maximum brachial artery 
FMD (FMDmax%) was 9.4% ±4.7% (0.5%–19.7%), 
while the  mean RHI was 1.8  ±0.4  (1.0–3.1). 
The mean maximum NMD (NMDmax%) was 13.8% 
±6% (4.07%–39.5%). The values of FMDmax var‑
ied significantly more than those of RHI. Impor‑
tantly, becasue the data for FMD, NMD, or RHI 
were not normally distributed, we performed 
the Box–Cox transformation to achieve normal 
data distribution in subsequent statistical anal‑
yses (FIGuRE 1AbC).
Correlations between the measures of endothelial 
dysfunction Despite the differences in variabil‑
ity of the studied parameters of endothelial dys‑
function, we observed a modest but statistical‑
ly significant correlation between RHI and FMD 
(r = 0.35, P = 0.001; FIGuRE 2A), while no associa‑
tion was found between RHI and NMD (r = 0.05, 
P = 0.6; FIGuRE 2b).
Correlations between the measures of endotheli‑
al function and carotid atherosclerosis The IMT 
values in the study group were not pathological 
TAbLE 1 Clinical characteristics of the subjects (n = 80)
Characteristics Values
age, y 43.6 ±14.8
sex, male/female, n (%) 52/28 (65/35)
BMI, kg/m2 28.4 ±6.1
overweight/obesity (BMI ≥25.0 kg/m2), n (%) 51 (63.7)
coronary artery disease, n (%) 11 (13.8)
CRP, mg/l 3.24 ±3.5
TC, mmol/l 5.3 ±1.0
hypercholesterolemia (TC ≥5.0 mmol/l), n (%) 53 (66.2)
arterial hypertension, n (%) 41 (51.2)
SBP, mmHg 129 ±13.4
DBP, mmHg 79.3 ±9.5
smoking, n (%) 16 (20)
type 2 diabetes, n (%) 6 (7.5)
PAD/stroke/TIA 0 (0)
main medications
aspirin 17 (21.3)
ACEIs/ARBs 40 (50)
diuretic 35 (43.7)
β‑blocker 33 (41.2)
statin 33 (41.2)
oral hypoglycemic 6 (7.5)
insulin 0 (0)
Data are presented as number (percentage) or as mean ± SD where appropriate.
Abbreviations: ACEI – angiotensin‑converting‑enzyme inhibitor, ARB – angiotensin 
receptor blocker, BMI – body mass index, CRP – C‑reactive protein, DBP – diastolic 
blood pressure, PAD – peripheral artery disease, SBP – systolic blood pressure, SD – 
standard deviation, TC – total cholesterol, TIA – transient ischemic attack
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which categorizes patients into 3 RHI zones re‑
flecting endothelial health. However, at the same 
time, sensitivity of RH‑PAT/RHI for the detection 
of the effects of numerous conditions on endo‑
thelial function has been questioned.13
In the present study, we compared classical bra‑
chial artery FMD with RHI in the measurement 
of the effects of the major atherosclerotic risk 
factors on the endothelial function. Our popula‑
tion was characterized by low carotid IMT and a 
low‑to‑moderate SCORE risk. We found that RHI 
significantly correlated with FMD. However, while 
FMD significantly correlated with the degree of 
carotid atherosclerosis measured by IMT or with 
a risk factor profile, RHI failed to show such corre‑
lations. This led us to conclude that while the RHI 
remains an interesting modality for measuring 
vascular function, the component of non‑nitric 
oxide‑mediated dilation effects may be so strong 
that it does not allow to detect the relationships 
with the measures of IMT or with the major ath‑
erosclerotic risk factors. Possibly when the dif‑
ferences in the endothelial function are dramat‑
ic and substantial, such as the recently reported 
differences in sex or race, the RHI could be use‑
ful.18 This is also in line with a recent study show‑
ing that FMD was weakly associated with the RHI 
in patients with atherosclerosis, but not among 
control subjects.19
We  showed that brachial artery dilation 
(FMDmax%) modestly correlates with the RHI. 
A similar positive correlation between FMDmax% 
and RHI was shown by several previous stud‑
ies.15,17,20,21 However, other studies did not ob‑
serve such correlation.22‑24 The discrepancies be‑
tween the studies have been attributed to popu‑
lation characteristics and methods of FMD mea‑
surement. Of note, similarly to our study, reports 
showing the relationship between RHI and FMD 
indicated that it was of modest‑to‑low degree.
Interestingly, when we then compared the re‑
lationship between classical major risk factors for 
atherosclerosis, such as diabetes, hypercholester‑
olemia, smoking, and hypertension, with FMD or 
RHI, we did not observe an expected association 
between a decrease in the RHI and the number of 
coexisting risk factors, while FMD decreased sig‑
nificantly. These results are in line with those by 
Bonetti et al.,17 who reported an association be‑
tween coronary artery endothelial function (cor‑
onary artery response to acetylcholine) and RHI 
but did not observe an association between RHI 
and total cholesterol level, blood pressure, dia‑
betes, and smoking. While initial studies demon‑
strated links to classical cardiovascular risk fac‑
tors,21,25,26 a number of recent studies have shown 
no difference in the RHI despite widely reported 
and expected endothelial dysfunction in these 
conditions.13 These data, in combination with 
our current report, suggest caution when recom‑
mending peripheral arterial tonometry for cardio‑
vascular risk stratification, but do not exclude its 
usefulness. A low RH signal detected by RH‑PAT, 
has been shown to be associated with a higher 
dIsCussION Increasing understanding of 
the significance of endothelial dysfunction in 
the development of cardiovascular diseases cre‑
ates an urgent need for the development of a sim‑
ple, reproducible, and sensitive measure of assess‑
ing endothelial function. While brachial artery 
FMD has served this purpose so far, it is techni‑
cally challenging, relatively complex, and the re‑
sults are difficult to compare between clinical lab‑
oratories. Therefore, an introduction of a sim‑
plified method based on the measurement of re‑
active hyperemia (RH‑PAT; RHI measurement) 
has been welcomed with enthusiasm, and an in‑
creasing number of studies have reported using 
this technique for endothelial function assess‑
ment.17 The EndoScore scale has been introduced, 
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rate of cardiac events in a 7‑year follow‑up of over 
200 subjects.27 However, more and more data in‑
dicate that this may be the case only with respect 
to carefully selected clinical subpopulations such 
as patients with metabolic syndrome or initially 
high cardiovascular risk.
One of the most comprehensive reports on RHI 
has been provided by Hamburg et al.23 who in‑
cluded over 4000 subjects. They found that while 
FMD represented endothelial dysfunction related 
to aging, hypertension, and obesity, the abnormal 
PAT ratio has been associated with lower systolic 
blood pressure, increasing total/high‑density li‑
poprotein cholesterol ratio, diabetes, and smok‑
ing. Interestingly, the PAT ratio was not associ‑
ated with FMD.23 Thus, the brachial and digital 
measures of vascular function provide distinct 
information and relate to different clinical con‑
ditions.23 This makes the RHI complementary to 
FMD but unlikely to substitute it.
There are also several other modalities for 
the assessment of vascular function, such 
as the cold pressor test or ultrasonograph‑
ic detection of vasomotor responses of the 
left anterior descending coronary artery, which 
can be used as complementary methods, although 
RHI will remain a valuable and simple alternative.9
Obviously, there may be numerous method‑
ological reasons for the differences in endothe‑
lial function assessment utilizing both methods. 
FIGuRE 3 Correlations between the mean 
intima‑media thickness (IMTmean) and maximum 
flow‑mediated dilation (FMDmax%; A), nitroglycerin‑ 
‑mediated dilation (NMDmax%; b) or reactive hyperemia 
index (RHI; C); data represent the actual values of IMT, 
FMD, or RHI for better visualization of the correlations; 
correlation values represent the Spearman’s correlation 
coefficient
FIGuRE 2 Correlations between reactive hyperemia 
index (RHI) and maximum flow‑mediated dilation 
(FMDmax%; A) or between RHI and nitroglycerin‑mediated 
dilation (NMDmax%; b); data are presented after the Box–
Cox transformation; Spearman’s correlation analysis is 
presented on the graphs
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FIGuRE 5 Correlations between the number of atherosclerotic risk factors and maximum flow‑mediated dilation (FMDmax%) (P <0.05; A), maximum 
nitroglycerin‑mediated dilation (NMDmax%) (P = 0.07; b), mean intima‑media thickness (IMTmean) (P <0.05; C), and reactive hyperemia index (RHI) (P = 0.54; d;)  
the following risk factors were considered: diabetes, hypercholesterolemia, smoking, and hypertension (see the Methods section); data represent the actual 
values of IMT, FMD, or RHI for better visualization of correlations; dots represent median values, boxes represent 25%–75% percentiles, and whiskers represent 
minimum and maximum values; correlation values represent Spearman’s correlation coefficient
FIGuRE 4 Differences in 
maximum brachial artery 
flow‑mediated dilation 
(FMD max%; A) or nitroglycerin‑ 
‑mediated dilation 
(NMDmax%; b) and mean 
intima–media thickness 
(IMTmean; C) and reactive 
hyperemia index (RHI; d) 
between subjects with 
at least 1 atherosclerotic risk 
factor (n = 69) and controls 
(n = 11); data represent 
the actual values of IMT, FMD, 
or RHI for better visualization 
of correlations; dots represent 
median values, boxes 
represent 25%–75% 
percentiles, and whiskers 
represent minimum and 
maximum values;  
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elsewhere.31 Similarly, the Bland–Altman analysis 
showed high reproducibility of the measurements.
As both RHI and FMD measurements were per‑
formed, a concern could be raised that the prior 
measurement affected the subsequent one. There‑
fore, nitroglycerin was always applied at the end 
of the experiment and at least 30 min of rest was 
allowed between the measurements involving 
a reactive hyperemia stimulus. This is sufficient 
because in a recent study, Barton et al.32 demon‑
strated that 15 min is a minimum recovery time 
between a reactive hyperemia stimulus in repeat‑
ed measurements of brachial FMD.
Finally, the sample size in our study may not 
be sufficient to fully discriminate the effects of 
individual risk factors in a multivariate analysis, 
which should be kept in mind when interpreting 
the results presented in TAbLEs 2 and 3.
In summary, our study indicates that FMD, 
despite its technical requirements and operator‑ 
‑dependence, is a more sensitive method than 
RH‑PAT for assessing the effects of classical ath‑
erosclerotic risk factors. It also allows to assess 
additional parameters such as blood flow, flow‑ 
‑mediated constriction, and baseline brachial ar‑
tery diameter. It is now important to determine 
clinical populations in which RH‑PAT might bet‑
ter serve risk stratification. Of note, while even 
in 80 subjects hypertension was associated with 
reduced FMD, hypercholesterolemia was more re‑
lated to RH‑PAT in a multivariate analysis. It is 
FMD measures macrovascular response (brachi‑
al artery), while RH‑PAT measures microvascular 
response, which may be more variable and may 
depend on many more factors than just endothe‑
lial nitric oxide release.15
In the present study, we also assessed the rela‑
tionship between the severity of carotid athero‑
sclerosis (IMT) and the measures of endotheli‑
al dysfunction. As expected, an inverse correla‑
tion between FMD and IMT was observed. Sim‑
ilar observations have been reported in numer‑
ous populations making combination of these 
2 parameters a potent predictor and measure of 
atherosclerotic risk.28 However, we did not ob‑
serve a correlation between RHI and IMT. This 
is in contrast to a study by Fitch et al.29 who de‑
scribed such correlation in 54 healthy individu‑
als or to reports of a possible prognostic value of 
the PAT measurement for IMT progression.30 In‑
terestingly, most studies published to date were 
conducted in much younger populations than that 
in our study (mostly in adolescents).
Some methodological considerations of FMD 
and IMT assessments include its interobserver 
and intraobserver measurement variability. In 
our study, the measurements were always per‑
formed by the same 2 experienced operators. Cor‑
relation coefficients for these variabilities in FMD 
measurements performed by experienced inves‑
tigators were high and in our laboratory equaled 
to 0.98, which is in line with the values reported 
TAbLE 2 Differences in flow‑mediated dilation in relation to individual major risk factors of atherosclerosis
FMD, %
risk factors with factor, n no factor, n with RF no RF P (univariate)a P (multivariate type III 
sums of squares)a
hypercholesterolemia 53 27 8.9 ±4.9 10.3 ±4.4 0.17 0.6
hypertension 41 39 6.6 ±3.4 12.3 ±4.2 <0.01 <0.01
smoking 16 64 8.2 ±3.6 9.7 ±4.9 0.37 0.6
diabetes 6 74 6.5 ±2.4 9.6 ±4.8 <0.05 0.7
overweight/obesity 51 29 7.8 ±4.1 12.2 ±4.4 <0.05 0.1
Data are presented as mean ± SD.
a statistical analysis was performed on Box–Cox‑transformed values
Abbreviations: FMD – flow‑mediated dilation, RF – risk factor, others – see TAbLE 1
TAbLE 3 Differences in reac tive hyperemia index in relation to individual major risk factors of atherosclerosis
RHI
risk factors with factor, n no factor, n with RF no RF P (univariate)a P (multivariate type III 
sums of squares)a
hypercholesterolemia 53 27 1.9 ±0.4 1.7 ±0.5 0.055 0.6
hypertension 41 39 1.77 ±0.4 1.83 ±0.4 0.5 <0.01
smoking 16 64 1.9 ±0.4 1.8 ±0.4 0.3 0.6
diabetes 6 74 1.6 ±0.3 1.8 ±0.4 0.4 0.7
overweight/obesity 51 29 1.7 ±0.4 1.8 ±0.4 0.7 0.1
Data are presented as mean ± SD.
a statistical analysis was performed on Box–Cox transformed values
Abbreviations: RHI – reactive hyperemia index, others – see TAbLE 1
ORIGINAL ARTICLE Endothelial function assessment in atherosclerosis 451
18 Morris AA, Patel RS, Binongo JN, et al. Racial differences in arterial 
stiffness and microcirculatory function between black and white americans. 
J Am Heart Assoc. 2013; 2: e002 154.
19 Kiani S, Aasen JG, Holbrook M, et al. Peripheral artery disease is as‑
sociated with severe impairment of vascular function. Vasc Med. 2013; 18: 
72‑78.
20 Heffernan KS, Karas RH, Mooney PJ, et al. Pulse wave amplitude is as‑
sociated with brachial artery diameter: implications for gender differences 
in microvascular function. Vasc Med. 2010; 15: 39‑45.
21 Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascu‑
lar endothelial function with finger arterial pulse wave amplitude. Am Heart 
J. 2003; 146: 168-174.
22 Allan RB, Delaney CL, Miller MD, Spark JI. A Comparison of Flow-me‑
diated Dilatation and Peripheral Artery Tonometry for Measurement of Endo‑
thelial Function in Healthy Individuals and Patients with Peripheral Arterial 
Disease. Eur J Vasc Endovasc Surg. 2013; 45: 263-269.
23 Hamburg NM, Palmisano J, Larson MG, et al. Relation of brachial and 
digital measures of vascular function in the community: the Framingham 
heart study. Hypertension. 2011; 57: 390‑396.
24 Aizer J, Karlson EW, Chibnik LB, et al. A controlled comparison of bra‑
chial artery flow mediated dilation (FMD) and digital pulse amplitude tonom‑
etry (PAT) in the assessment of endothelial function in systemic lupus ery‑
thematosus. Lupus. 2009; 18: 235‑242.
25 Toggweiler S, Schoenenberger A, Urbanek N, Erne P. The prevalence of 
endothelial dysfunction in patients with and without coronary artery disease. 
Clin Cardiol. 2010; 33: 746‑752.
26 Bonetti PO, Lardi E, Geissmann C, et al. Effect of brief secondhand 
smoke exposure on endothelial function and circulating markers of inflam‑
mation. Atherosclerosis. 2011; 215: 218‑222.
27 Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial 
function by non‑invasive peripheral arterial tonometry predicts late cardio‑
vascular adverse events. Eur Heart J. 2010; 31: 1142-1148.
28 Juonala M, Viikari JS, Laitinen T, et al. Interrelations between bra‑
chial endothelial function and carotid intima‑media thickness in young 
adults: the cardiovascular risk in young Finns study. Circulation. 2004; 110: 
2918‑2923.
29 Fitch KV, Stavrou E, Looby SE, et al. Associations of cardiovascular 
risk factors with two surrogate markers of subclinical atherosclerosis: endo‑
thelial function and carotid intima media thickness. Atherosclerosis. 2011; 
217: 437‑440.
30 Ferré R, Plana N, Merino J, et al. Effects of therapeutic lifestyle chang‑
es on peripheral artery tonometry in patients with abdominal obesity. Nutr 
Metab Cardiovasc Dis. 2012; 22: 95‑102.
31 Simova I, Nossikoff A, Denchev S. Interobserver and intraob‑
server variability of flow‑mediated vasodilatation of the brachial artery. 
Echocardiography. 2008; 25: 77‑83.
32 Barton M, Turner AT, Newens KJ, et al. Minimum recovery time be‑
tween reactive hyperemia stimulus in the repeated measurement of brachial 
flow‑mediated dilatation. Ultrasound Med Biol. 2011; 37: 879‑883.
also possible that RHI/RH‑PAT may be more sen‑
sitive when repeated measurements in the same 
patient are necessary, such as in studies on the ef‑
fects of various treatments and medications on 
endothelial function. RH‑PAT would eliminate 
the confounding factors associated with FMD. 
We also need a more detailed physiological re‑
sponse characteristics of microvasculature during 
RH‑PAT study to address the issue of endotheli‑
um vs. non‑endothelium dependence of record‑
ed responses and understand the effects of sym‑
pathetic nervous system activity21 before we can 
further consider RH‑PAT as universal tool for en‑
dothelial health stratification.
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sTREszCzENIE
wPROwAdzENIE Dysfunkcja śródbłonka, charakteryzująca się utratą biodostępności tlenku azotu, jest 
kluczowym elementem w patogenezie miażdżycy i ważnym czynnikiem prognostycznym w schorzeniach 
sercowo-naczyniowych. Dlatego rozwój wiarygodnych, bezpiecznych i nieinwazyjnych metod pomiaru 
funkcji śródbłonka naczyniowego jest kluczowy, aby można je było wykorzystywać w stratyfikacji 
ryzyka sercowo-naczyniowego. Pomiar rozkurczu naczyń pod wpływem zwiększonego przepływu krwi 
(flow‑mediated dilation – FMD) jest metodą szeroko stosowaną w badaniach naukowych, jednak trud‑
ności techniczne i problemy z kalibracją wartości pomiędzy laboratoriami ograniczają jej zastosowania 
kliniczne. Obwodowa tonometria tętnicza wykorzystująca zjawisko reaktywnej hiperemii (reactive 
hyperemia–peripheral artery tonometry – RH-PAT, Endo-PAT) została opracowana jako prostsza, tańsza 
i potencjalnie bardziej powtarzalna metoda.
CELE Celem pracy było zbadanie związków pomiędzy pomiarami FMD a RH-PAT w odniesieniu do profilu 
czynników ryzyka miażdżycy.
PACjENCI I mETOdy Do badania włączono 80 pacjentów (52 mężczyzn, 28 kobiet), w wieku 43,6 ±14,8 
roku z umiarkowanym i niskim ryzykiem sercowo-naczyniowym (średnia wartość SCORE = 2,2 ±2%), 
u których badano FMD, RH-PAT oraz grubość błony wewnętrznej i środkowej (intima–media thickness – IMT).
wyNIKI Pomiar indeksu reaktywnej hiperemii (reactive hyperemia index – RHI) za pomocą RH-PAT 
znamiennie korelował z pomiarami FMD (r = 0,35; p <0,01). Nie zaobserwowano jednak znamiennej 
korelacji między RHI a IMT, SCORE ani liczbą klasycznych czynników ryzyka miażdżycy (nadciśnienie, 
palenie, cukrzyca, hipercholesterolemia), podczas gdy FMD wykazywało znamienną korelację z IMT 
(r = –0,53; p <0,001), czynnikami ryzyka miażdżycy (r = –0,55; p <0,05) oraz wartością SCORE 
(r = –0,4; p <0,05).
wNIOsKI FMD, mimo wymogów technicznych, jest metodą bardziej czułą niż RH-PAT, w odniesieniu 
do oceny wpływu klasycznych czynników ryzyka miażdżycy na funkcję śródbłonka naczyniowego. Odpowiedź 
mikronaczyniowa na hiperemię podczas badania za pomocą RH-PAT musi być bardziej szczegółowo zbadana, 
z określeniem znaczenia czynników niezależnych od śródbłonka, które mogą wpływać na wykonywane 
pomiary, zanim RH-PAT będzie można uznać za uniwersalne narzędzie oceny stanu komórek śródbłonka.
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